Botanix Pharmaceuticals (BOT) has had its application to use the novel sofpironium bromide gel to treat primary axillary hyperhidrosis rejected by the US Food and Drug Administration (FDA).Source:
https://themarketherald.com.au/botanix-pharmaceuticals-asxbot-suffers-setback-in-fda-approval-for-sofpironium-bromide-gel-to-treat-hyperhidrosis-2023-09-26/
there is no guarantee that by mid 2024 it will be given the approval and it may well get rejected again if the management stuffs up again .
It is up to people what they choose to believe.
Many will always tell you to BUY
Some will always tell you to SELL
but then we have a very few who will do both as per what the market and the smart money is telling them.
Make your investment decisions wisely and always DYOR.
Botanix Pharmaceuticals (BOT) has had its application to use the...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.010(4.26%) |
Mkt cap ! $378.0M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.5¢ | 23.5¢ | $564.6K | 2.338M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 518001 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 97502 | 1 |
View Market Depth
| Last trade - 11.06am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
24.3¢ |
Change
0.010 ( 3.19 %) |
||||
| Open | High | Low | Volume | ||
| 24.0¢ | 24.5¢ | 24.0¢ | 748491 | ||
| Last updated 11.16am 02/05/2024 ? | |||||
| BOT (ASX) Chart |